TB Diagnostic Market Report

Global TB Diagnostic Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：170
  • REPORT CODE：GMM872405
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • TB Diagnostic market report explains the definition, types, applications, major countries, and major players of the TB Diagnostic market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • bioMrieux

    • F Hoffman La Roche

    • Abbott Laboratories

    • Hologic Corporation

    • Qiagen

    • Becton Dickinson and Company

    • Cepheid

    • Thermo Fisher Scientific

    • Hain Lifescience

    • Alere

    By Type:

    • Radiographic Method

    • Diagnostic Laboratory Methods

    • Nucleic Acid Testing

    • Phage Assay

    • Detection of Latent Infection

    • Cytokine Detection Assay

    • Detection of Drug Resistance

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global TB Diagnostic Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 TB Diagnostic Outlook to 2028- Original Forecasts

    • 2.2 TB Diagnostic Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term TB Diagnostic Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global TB Diagnostic Market- Recent Developments

    • 6.1 TB Diagnostic Market News and Developments

    • 6.2 TB Diagnostic Market Deals Landscape

    7 TB Diagnostic Raw Materials and Cost Structure Analysis

    • 7.1 TB Diagnostic Key Raw Materials

    • 7.2 TB Diagnostic Price Trend of Key Raw Materials

    • 7.3 TB Diagnostic Key Suppliers of Raw Materials

    • 7.4 TB Diagnostic Market Concentration Rate of Raw Materials

    • 7.5 TB Diagnostic Cost Structure Analysis

      • 7.5.1 TB Diagnostic Raw Materials Analysis

      • 7.5.2 TB Diagnostic Labor Cost Analysis

      • 7.5.3 TB Diagnostic Manufacturing Expenses Analysis

    8 Global TB Diagnostic Import and Export Analysis (Top 10 Countries)

    • 8.1 Global TB Diagnostic Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global TB Diagnostic Export by Region (Top 10 Countries) (2017-2028)

    9 Global TB Diagnostic Market Outlook by Types and Applications to 2022

    • 9.1 Global TB Diagnostic Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Radiographic Method Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Diagnostic Laboratory Methods Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Nucleic Acid Testing Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Phage Assay Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Detection of Latent Infection Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Cytokine Detection Assay Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Detection of Drug Resistance Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global TB Diagnostic Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise TB Diagnostic Market Analysis and Outlook till 2022

    • 10.1 Global TB Diagnostic Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States TB Diagnostic Consumption (2017-2022)

      • 10.2.2 Canada TB Diagnostic Consumption (2017-2022)

      • 10.2.3 Mexico TB Diagnostic Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany TB Diagnostic Consumption (2017-2022)

      • 10.3.2 UK TB Diagnostic Consumption (2017-2022)

      • 10.3.3 Spain TB Diagnostic Consumption (2017-2022)

      • 10.3.4 Belgium TB Diagnostic Consumption (2017-2022)

      • 10.3.5 France TB Diagnostic Consumption (2017-2022)

      • 10.3.6 Italy TB Diagnostic Consumption (2017-2022)

      • 10.3.7 Denmark TB Diagnostic Consumption (2017-2022)

      • 10.3.8 Finland TB Diagnostic Consumption (2017-2022)

      • 10.3.9 Norway TB Diagnostic Consumption (2017-2022)

      • 10.3.10 Sweden TB Diagnostic Consumption (2017-2022)

      • 10.3.11 Poland TB Diagnostic Consumption (2017-2022)

      • 10.3.12 Russia TB Diagnostic Consumption (2017-2022)

      • 10.3.13 Turkey TB Diagnostic Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China TB Diagnostic Consumption (2017-2022)

      • 10.4.2 Japan TB Diagnostic Consumption (2017-2022)

      • 10.4.3 India TB Diagnostic Consumption (2017-2022)

      • 10.4.4 South Korea TB Diagnostic Consumption (2017-2022)

      • 10.4.5 Pakistan TB Diagnostic Consumption (2017-2022)

      • 10.4.6 Bangladesh TB Diagnostic Consumption (2017-2022)

      • 10.4.7 Indonesia TB Diagnostic Consumption (2017-2022)

      • 10.4.8 Thailand TB Diagnostic Consumption (2017-2022)

      • 10.4.9 Singapore TB Diagnostic Consumption (2017-2022)

      • 10.4.10 Malaysia TB Diagnostic Consumption (2017-2022)

      • 10.4.11 Philippines TB Diagnostic Consumption (2017-2022)

      • 10.4.12 Vietnam TB Diagnostic Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil TB Diagnostic Consumption (2017-2022)

      • 10.5.2 Colombia TB Diagnostic Consumption (2017-2022)

      • 10.5.3 Chile TB Diagnostic Consumption (2017-2022)

      • 10.5.4 Argentina TB Diagnostic Consumption (2017-2022)

      • 10.5.5 Venezuela TB Diagnostic Consumption (2017-2022)

      • 10.5.6 Peru TB Diagnostic Consumption (2017-2022)

      • 10.5.7 Puerto Rico TB Diagnostic Consumption (2017-2022)

      • 10.5.8 Ecuador TB Diagnostic Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain TB Diagnostic Consumption (2017-2022)

      • 10.6.2 Kuwait TB Diagnostic Consumption (2017-2022)

      • 10.6.3 Oman TB Diagnostic Consumption (2017-2022)

      • 10.6.4 Qatar TB Diagnostic Consumption (2017-2022)

      • 10.6.5 Saudi Arabia TB Diagnostic Consumption (2017-2022)

      • 10.6.6 United Arab Emirates TB Diagnostic Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria TB Diagnostic Consumption (2017-2022)

      • 10.7.2 South Africa TB Diagnostic Consumption (2017-2022)

      • 10.7.3 Egypt TB Diagnostic Consumption (2017-2022)

      • 10.7.4 Algeria TB Diagnostic Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia TB Diagnostic Consumption (2017-2022)

      • 10.8.2 New Zealand TB Diagnostic Consumption (2017-2022)

    11 Global TB Diagnostic Competitive Analysis

    • 11.1 bioMrieux

      • 11.1.1 bioMrieux Company Details

      • 11.1.2 bioMrieux TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 bioMrieux TB Diagnostic Main Business and Markets Served

      • 11.1.4 bioMrieux TB Diagnostic Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 F Hoffman La Roche

      • 11.2.1 F Hoffman La Roche Company Details

      • 11.2.2 F Hoffman La Roche TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 F Hoffman La Roche TB Diagnostic Main Business and Markets Served

      • 11.2.4 F Hoffman La Roche TB Diagnostic Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Abbott Laboratories

      • 11.3.1 Abbott Laboratories Company Details

      • 11.3.2 Abbott Laboratories TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Abbott Laboratories TB Diagnostic Main Business and Markets Served

      • 11.3.4 Abbott Laboratories TB Diagnostic Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Hologic Corporation

      • 11.4.1 Hologic Corporation Company Details

      • 11.4.2 Hologic Corporation TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Hologic Corporation TB Diagnostic Main Business and Markets Served

      • 11.4.4 Hologic Corporation TB Diagnostic Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Qiagen

      • 11.5.1 Qiagen Company Details

      • 11.5.2 Qiagen TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Qiagen TB Diagnostic Main Business and Markets Served

      • 11.5.4 Qiagen TB Diagnostic Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Becton Dickinson and Company

      • 11.6.1 Becton Dickinson and Company Company Details

      • 11.6.2 Becton Dickinson and Company TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Becton Dickinson and Company TB Diagnostic Main Business and Markets Served

      • 11.6.4 Becton Dickinson and Company TB Diagnostic Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Cepheid

      • 11.7.1 Cepheid Company Details

      • 11.7.2 Cepheid TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Cepheid TB Diagnostic Main Business and Markets Served

      • 11.7.4 Cepheid TB Diagnostic Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Thermo Fisher Scientific

      • 11.8.1 Thermo Fisher Scientific Company Details

      • 11.8.2 Thermo Fisher Scientific TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Thermo Fisher Scientific TB Diagnostic Main Business and Markets Served

      • 11.8.4 Thermo Fisher Scientific TB Diagnostic Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Hain Lifescience

      • 11.9.1 Hain Lifescience Company Details

      • 11.9.2 Hain Lifescience TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Hain Lifescience TB Diagnostic Main Business and Markets Served

      • 11.9.4 Hain Lifescience TB Diagnostic Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Alere

      • 11.10.1 Alere Company Details

      • 11.10.2 Alere TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Alere TB Diagnostic Main Business and Markets Served

      • 11.10.4 Alere TB Diagnostic Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global TB Diagnostic Market Outlook by Types and Applications to 2028

    • 12.1 Global TB Diagnostic Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Radiographic Method Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Diagnostic Laboratory Methods Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Nucleic Acid Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Phage Assay Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Detection of Latent Infection Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Cytokine Detection Assay Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Detection of Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global TB Diagnostic Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise TB Diagnostic Market Analysis and Outlook to 2028

    • 13.1 Global TB Diagnostic Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States TB Diagnostic Consumption Forecast (2022-2028)

      • 13.2.2 Canada TB Diagnostic Consumption Forecast (2022-2028)

      • 13.2.3 Mexico TB Diagnostic Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.2 UK TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.3 Spain TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.4 Belgium TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.5 France TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.6 Italy TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.7 Denmark TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.8 Finland TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.9 Norway TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.10 Sweden TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.11 Poland TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.12 Russia TB Diagnostic Consumption Forecast (2022-2028)

      • 13.3.13 Turkey TB Diagnostic Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.2 Japan TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.3 India TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.4 South Korea TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.8 Thailand TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.9 Singapore TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.11 Philippines TB Diagnostic Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam TB Diagnostic Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil TB Diagnostic Consumption Forecast (2022-2028)

      • 13.5.2 Colombia TB Diagnostic Consumption Forecast (2022-2028)

      • 13.5.3 Chile TB Diagnostic Consumption Forecast (2022-2028)

      • 13.5.4 Argentina TB Diagnostic Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela TB Diagnostic Consumption Forecast (2022-2028)

      • 13.5.6 Peru TB Diagnostic Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico TB Diagnostic Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador TB Diagnostic Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain TB Diagnostic Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait TB Diagnostic Consumption Forecast (2022-2028)

      • 13.6.3 Oman TB Diagnostic Consumption Forecast (2022-2028)

      • 13.6.4 Qatar TB Diagnostic Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia TB Diagnostic Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates TB Diagnostic Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria TB Diagnostic Consumption Forecast (2022-2028)

      • 13.7.2 South Africa TB Diagnostic Consumption Forecast (2022-2028)

      • 13.7.3 Egypt TB Diagnostic Consumption Forecast (2022-2028)

      • 13.7.4 Algeria TB Diagnostic Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia TB Diagnostic Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand TB Diagnostic Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of TB Diagnostic

    • Figure of TB Diagnostic Picture

    • Table Global TB Diagnostic Import by Region (Top 10 Countries) (2017-2028)

    • Table Global TB Diagnostic Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Radiographic Method Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Laboratory Methods Consumption and Growth Rate (2017-2022)

    • Figure Global Nucleic Acid Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Phage Assay Consumption and Growth Rate (2017-2022)

    • Figure Global Detection of Latent Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Cytokine Detection Assay Consumption and Growth Rate (2017-2022)

    • Figure Global Detection of Drug Resistance Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global TB Diagnostic Consumption by Country (2017-2022)

    • Table North America TB Diagnostic Consumption by Country (2017-2022)

    • Figure United States TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Canada TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Mexico TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Table Europe TB Diagnostic Consumption by Country (2017-2022)

    • Figure Germany TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure UK TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Spain TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Belgium TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure France TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Italy TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Denmark TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Finland TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Norway TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Sweden TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Poland TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Russia TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Turkey TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Table APAC TB Diagnostic Consumption by Country (2017-2022)

    • Figure China TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Japan TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure India TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure South Korea TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Pakistan TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Indonesia TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Thailand TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Singapore TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Malaysia TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Philippines TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Vietnam TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Table South America TB Diagnostic Consumption by Country (2017-2022)

    • Figure Brazil TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Colombia TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Chile TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Argentina TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Venezuela TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Peru TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Ecuador TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Table GCC TB Diagnostic Consumption by Country (2017-2022)

    • Figure Bahrain TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Kuwait TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Oman TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Qatar TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Table Africa TB Diagnostic Consumption by Country (2017-2022)

    • Figure Nigeria TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure South Africa TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Egypt TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure Algeria TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Table Oceania TB Diagnostic Consumption by Country (2017-2022)

    • Figure Australia TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Figure New Zealand TB Diagnostic Consumption and Growth Rate (2017-2022)

    • Table bioMrieux Company Details

    • Table bioMrieux TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table bioMrieux TB Diagnostic Main Business and Markets Served

    • Table bioMrieux TB Diagnostic Product Portfolio

    • Table F Hoffman La Roche Company Details

    • Table F Hoffman La Roche TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffman La Roche TB Diagnostic Main Business and Markets Served

    • Table F Hoffman La Roche TB Diagnostic Product Portfolio

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories TB Diagnostic Main Business and Markets Served

    • Table Abbott Laboratories TB Diagnostic Product Portfolio

    • Table Hologic Corporation Company Details

    • Table Hologic Corporation TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hologic Corporation TB Diagnostic Main Business and Markets Served

    • Table Hologic Corporation TB Diagnostic Product Portfolio

    • Table Qiagen Company Details

    • Table Qiagen TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen TB Diagnostic Main Business and Markets Served

    • Table Qiagen TB Diagnostic Product Portfolio

    • Table Becton Dickinson and Company Company Details

    • Table Becton Dickinson and Company TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson and Company TB Diagnostic Main Business and Markets Served

    • Table Becton Dickinson and Company TB Diagnostic Product Portfolio

    • Table Cepheid Company Details

    • Table Cepheid TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cepheid TB Diagnostic Main Business and Markets Served

    • Table Cepheid TB Diagnostic Product Portfolio

    • Table Thermo Fisher Scientific Company Details

    • Table Thermo Fisher Scientific TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific TB Diagnostic Main Business and Markets Served

    • Table Thermo Fisher Scientific TB Diagnostic Product Portfolio

    • Table Hain Lifescience Company Details

    • Table Hain Lifescience TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hain Lifescience TB Diagnostic Main Business and Markets Served

    • Table Hain Lifescience TB Diagnostic Product Portfolio

    • Table Alere Company Details

    • Table Alere TB Diagnostic Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alere TB Diagnostic Main Business and Markets Served

    • Table Alere TB Diagnostic Product Portfolio

    • Figure Global Radiographic Method Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Laboratory Methods Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nucleic Acid Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Phage Assay Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Detection of Latent Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cytokine Detection Assay Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Detection of Drug Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Table North America TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure United States TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Germany TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure France TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure China TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure India TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table South America TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Brazil TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Bahrain TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Nigeria TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania TB Diagnostic Consumption Forecast by Country (2022-2028)

    • Figure Australia TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand TB Diagnostic Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US